Name: Maravai LifeSciences Holdings, Inc. (MRVI) Financial Statements
Creator: FinSpry

Maravai LifeSciences Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Maravai LifeSciences Holdings, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	259.19	288.95	883.00	799.24	284.10
Cost of Revenue	150.88	148.74	168.96	140.56	79.65
Gross Profit	108.31	140.20	714.04	658.68	204.45
Operating Expenses
Research & Development	19.22	17.28	18.37	15.22	6.42
Selling, General & Administrative	161.77	151.39	125.76	100.06	94.25
Operating Expenses	343.93	168.67	144.13	115.28	100.67
Operating Income	-235.62	-31.65	569.92	543.40	103.78
Other Income/Expense
Interest Income	27.40	27.73	2.34	0.00	0.00
Interest Expense	47.70	45.89	-20.41	-30.26	-30.74
Other Income/Expense	-25.87	664.37	-4.46	6.38	0.13
Income
Income Before Tax	-261.48	617.74	551.47	530.77	81.70
Income Tax Expense	-1.86	756.11	60.81	61.52	2.88
Net Income	-144.85	-119.03	220.21	182.04	88.97
Net Income - Continuous Operations	-144.85	-138.38	490.66	469.25	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-156.92	712.41	601.75	568.15	129.62
EBIT	-258.79	663.63	569.92	543.40	103.78
Depreciation & Amortization	56.87	12.90	31.84	24.75	25.84
Earnings Per Share
Basic EPS	-1.00	-1.00	2.00	2.00	7.00
Diluted EPS	-1.00	-1.00	2.00	2.00	2.00
Basic Shares Outstanding	137.91	131.92	131.55	114.79	10.35
Diluted Shares Outstanding	137.91	131.92	255.32	257.80	28.91